• Explore /
  • Poster
  • / Exposure toxicity and response relationship of cabozantinib (CABO) in patients with metastatic renal cell carcinoma (mRCC).

Exposure toxicity and response relationship of cabozantinib (CABO) in patients with metastatic renal cell carcinoma (mRCC).

Abstract Poster

Authors

null

Alexandre Xu-Vuillard

Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP.Centre – Université Paris Cité, Paris, France, Paris, France

Alexandre Xu-Vuillard , Anne Jouinot , Thomas Pudlarz , Benoit Blanchet , Olivier Huillard , Charlotte Joly , Christophe Tournigand , Stephane Oudard , Jacques Medioni , Yann-Alexandre Vano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 676)

DOI

10.1200/JCO.2023.41.6_suppl.676

Abstract #

676

Poster Bd #

H8

Abstract Disclosures

Similar Posters

First Author: Ana-Alicia Beltran-Bless

First Author: Luigi Cerbone

First Author: Giuseppe Procopio

First Author: Chun Loo Gan